Literature DB >> 24858410

Morphological and molecular changes of human granulosa cells exposed to 5-azacytidine and addressed toward muscular differentiation.

Tiziana A L Brevini1, Georgia Pennarossa, Mahbubur M Rahman, Alessio Paffoni, Stefania Antonini, Guido Ragni, Magda deEguileor, Gianluca Tettamanti, Fulvio Gandolfi.   

Abstract

Converting adult cells from one cell type to another is a particularly interesting idea for regenerative medicine. Terminally differentiated cells can be induced to de-differentiate in vitro to become multipotent progenitors. In mammals these changes do not occur naturally, however exposing differentiated adult cells to synthetic molecules capable of selectively reverting cells from their lineage commitment to a more plastic state makes it possible to re-address their fate. Only scattered information are available on the morphological changes and ultrastructural remodeling taking place when cells convert into a different and specific type. To better clarify these aspects, we derived human granulosa cell (GC) primary cultures and analyzed the morphological changes taking place in response to the exposure to the epigenetic modifier 5-azacytidine (5-aza-CR) and to the treatment with VEGF, as a stimulus for inducing differentiation into muscle cells. Ultrastructural modifications and molecular marker expression were analyzed at different intervals during the treatments. Our results indicate that the temporary up regulation of pluripotency markers is accompanied by the loss of GC-specific ultrastructural features, mainly through autophagocitosis, and is associated with a temporary chromatin decondensation. After exposure to VEGF the induction of muscle specific genes was combined with the appearance of multinucleated cells with a considerable quantity of non-spatially organized filaments. The detailed analysis of the morphological changes occurring in cells undergoing lineage re-addressing allows a better understanding of these process and may prove useful for refining the use of somatic cells in regenerative medicine and tissue replacement therapies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858410     DOI: 10.1007/s12015-014-9521-4

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  44 in total

Review 1.  Mitochondria in stem cells.

Authors:  Thomas Lonergan; Barry Bavister; Carol Brenner
Journal:  Mitochondrion       Date:  2007-05-23       Impact factor: 4.160

2.  Dissecting direct reprogramming through integrative genomic analysis.

Authors:  Tarjei S Mikkelsen; Jacob Hanna; Xiaolan Zhang; Manching Ku; Marius Wernig; Patrick Schorderet; Bradley E Bernstein; Rudolf Jaenisch; Eric S Lander; Alexander Meissner
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

3.  Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells.

Authors:  Chih-Chien Tsai; Pei-Fen Su; Yi-Feng Huang; Tu-Lai Yew; Shih-Chieh Hung
Journal:  Mol Cell       Date:  2012-07-12       Impact factor: 17.970

4.  Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity.

Authors:  Claudia Piccoli; Roberto Ria; Rosella Scrima; Olga Cela; Annamaria D'Aprile; Domenico Boffoli; Franca Falzetti; Antonio Tabilio; Nazzareno Capitanio
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

5.  Actions of epidermal growth factor receptor/mitogen-activated protein kinase and protein kinase C signaling in granulosa cells from Gallus gallus are dependent upon stage of differentiation.

Authors:  Dori C Woods; Morgan J Haugen; A L Johnson
Journal:  Biol Reprod       Date:  2007-04-04       Impact factor: 4.285

6.  Chromatin decondensation and nuclear reprogramming by nucleoplasmin.

Authors:  Hiroshi Tamada; Nguyen Van Thuan; Peter Reed; Dominic Nelson; Nobuko Katoku-Kikyo; Justin Wudel; Teruhiko Wakayama; Nobuaki Kikyo
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 7.  Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape.

Authors:  Bernadett Papp; Kathrin Plath
Journal:  Cell Res       Date:  2011-02-15       Impact factor: 25.617

8.  The imitation switch ATPase Snf2l is required for superovulation and regulates Fgl2 in differentiating mouse granulosa cells.

Authors:  David Pépin; François Paradis; Carol Perez-Iratxeta; David J Picketts; Barbara C Vanderhyden
Journal:  Biol Reprod       Date:  2013-06-06       Impact factor: 4.285

9.  Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells.

Authors:  Georgia Pennarossa; Sara Maffei; Marino Campagnol; Letizia Tarantini; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  15 in total

Review 1.  Erase and Rewind: Epigenetic Conversion of Cell Fate.

Authors:  Georgia Pennarossa; Alessandro Zenobi; Cecilia E Gandolfi; Elena F M Manzoni; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

Review 2.  Autophagy and cell reprogramming.

Authors:  Shuo Wang; Pengyan Xia; Markus Rehm; Zusen Fan
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

3.  Use of a PTFE Micro-Bioreactor to Promote 3D Cell Rearrangement and Maintain High Plasticity in Epigenetically Erased Fibroblasts.

Authors:  Georgia Pennarossa; Elena F M Manzoni; Sergio Ledda; Magda deEguileor; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

Review 4.  Chemical transdifferentiation: closer to regenerative medicine.

Authors:  Aining Xu; Lin Cheng
Journal:  Front Med       Date:  2016-05-03       Impact factor: 4.592

Review 5.  All roads lead to Rome: the many ways to pluripotency.

Authors:  G Pennarossa; F Gandolfi; T A L Brevini
Journal:  J Assist Reprod Genet       Date:  2020-03-20       Impact factor: 3.412

6.  Epigenetic Erasing and Pancreatic Differentiation of Dermal Fibroblasts into Insulin-Producing Cells are Boosted by the Use of Low-Stiffness Substrate.

Authors:  Georgia Pennarossa; Rosaria Santoro; Elena F M Manzoni; Maurizio Pesce; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

7.  Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Sara Maffei; Alessandro Zenobi; Fulvio Gandolfi
Journal:  J Vis Exp       Date:  2016-03-18       Impact factor: 1.355

8.  5-azacytidine affects TET2 and histone transcription and reshapes morphology of human skin fibroblasts.

Authors:  Elena F M Manzoni; Georgia Pennarossa; Magda deEguileor; Gianluca Tettamanti; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

Review 9.  The quest for an effective and safe personalized cell therapy using epigenetic tools.

Authors:  T A L Brevini; G Pennarossa; E F M Manzoni; C E Gandolfi; A Zenobi; F Gandolfi
Journal:  Clin Epigenetics       Date:  2016-11-16       Impact factor: 6.551

10.  Muscle Cell Morphogenesis, Structure, Development and Differentiation Processes Are Significantly Regulated during Human Ovarian Granulosa Cells In Vitro Cultivation.

Authors:  Claudia Dompe; Wiesława Kranc; Karol Jopek; Katarzyna Kowalska; Sylwia Ciesiółka; Błażej Chermuła; Artur Bryja; Maurycy Jankowski; Joanna Perek; Małgorzata Jozkowiak; Lisa Moncrieff; Greg Hutchings; Krzysztof Janowicz; Leszek Pawelczyk; Małgorzata Bruska; James Petitte; Paul Mozdziak; Magdalena Kulus; Hanna Piotrowska-Kempisty; Robert Z Spaczyński; Michał Nowicki; Bartosz Kempisty
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.